SCHEMBL7363482

SCHEMBL7363482

CCOC(=O)CCN1CC(=O)N(Cc2ccc(Cl)cc2)c2ccc(C#Cc3ccc(C(=N)N)cc3)cc2C1=O

nearest known ligand 0.59

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 18/20 0.59
ITGA2B P08514 18/20 0.59
F2 P00734 1/20 0.36
F10 P00742 1/20 0.36
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7330729 0.90 ITGB3 (0.65) ITGB3ITGA2BF2F10
SCHEMBL7330016 0.89 ITGB3 (0.44) ITGB3ITGA2B
SCHEMBL8837116 0.89 ITGB3 (0.72) ITGB3ITGA2BHDAC1HDAC2HDAC8
SCHEMBL7363243 0.87 ITGB3 (0.55) ITGB3ITGA2BF2HDAC1HDAC2
SCHEMBL7361556 0.87 ITGB3 (0.47) ITGB3ITGA2BF2F10
SCHEMBL7331027 0.87 ITGB3 (0.61) ITGB3ITGA2BF2F10
SCHEMBL7330685 0.86 ITGB3 (0.78) ITGB3ITGA2BF2F10
Trifluoroacetic Acid SCHEMBL7363241 0.85 ITGB3 (0.66) ITGB3ITGA2BHDAC1HDAC2HDAC8
SCHEMBL7322854 0.83 ITGB3 (0.63) ITGB3ITGA2BF2F10
Trifluoroacetic Acid SCHEMBL7326019 0.83 ITGB3 (0.45) ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5674863-A BENZODIAZEPINEDIONE DERIVATIVE; FIBRINOGIN BINDING INHIBITOR GENENTECH, INC. (US) 1997-10-07 US disclosed
US-5674865-A BENZODIAZEPINEDIONE DERIVATIVE; FIBRINOGIN BINDING INHIBITOR GENENTECH, INC. (US) 1997-10-07 US disclosed
US-5663166-A ANTICOAGULANTS OF 1,4-BENZODIAZEPINE-2,5-DIONE AND 2-BENZOAZEPINE-1,4-DIONE DERIVATIVES; PREVENTS FIBRINOGEN BINDING NECESSARY FOR PLATELET AGGREGATION; SIDE EFFECT REDUCTION, E.G. EXCESSIVE BLEEDING GENENTECH, INC. (US) 1997-09-02 US disclosed
US-5565449-A PLATELET AGGREGATION INHIBITORS GENENTECH, INC. (US) 1996-10-15 US disclosed
EP-0610334-B1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII B III A RECEPTOR GENENTECH INC (US) 1996-01-24 EP disclosed
EP-0610334-A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII b?III a? RECEPTOR. GENENTECH INC (US) 1994-08-17 EP disclosed
WO-1993008174-A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPIIbIIIa RECEPTOR GENENTECH, INC. (US) 1993-04-29 WO disclosed